CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.2 CNY | -0.84% |
|
+0.66% | +13.98% |
| Apr. 26 | CR Double-Crane Pharmaceutical's Profit Rises 11% in Q1 as Revenue Grows 2% | MT |
| Apr. 26 | CR Double-Crane Pharmaceutical's Unit Gets Nod to Trial New Pain Medication | MT |
Evolution of the average Target Price on China Resources Double-Crane Pharmaceutical Co.,Ltd.
Price target over the last 5 years
History of analyst recommendation changes
31a7eb1e30ae8189deb8def82d8ab535._-6Kp0brMIgKSDu1M7nNE_lB512HrjXoBTcYUMWoTaU.z4vv1nGuQ8NYEk_eZsmEUJ4ylGzvyQyxTmJ2A5qeC5Slgr7NAKlV3U0qTA~c2ab8ac327437381d5528f414fa2cbed
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
21.2
CNY
Average target price
24.91
CNY
Spread / Average Target
+17.52%
High Price Target
26
CNY
Spread / Highest target
+22.64%
Low Price Target
23
CNY
Spread / Lowest Target
+8.49%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
B-
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- 600062 Stock
- Consensus China Resources Double-Crane Pharmaceutical Co.,Ltd.
